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Changes in ankle brachial index in symptomatic
and asymptomatic subjects in the general
population
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Objective: To determine changes over time in the ankle brachial index (ABI) among subjects with and without
intermittent claudication in the general population.
Design of study: Population cohort study.
Setting: General population in Edinburgh, Scotland.
Subjects: A total of 1592 men and women aged 55 to 74 years selected at random from age-sex registers of 11 general
practices and followed up over 12 years.
Main outcome measures: Changes in ABI for each leg recorded at baseline in 1988 and at subsequent 5-year and 12-year
clinical examinations.
Results: Overall, 695 subjects (348 men and 347 women) had valid ABI measurements on both legs at all three
examinations. At baseline, the ABI was on average .03 higher in the right leg than the left (P < .001). Men had a mean
ABI that was .07 higher than women (P < .001). Mean ABI in the worse leg showed little change over 12 years in both
men and women. However, in the whole population, the ABI in the better leg showed a significant drop, 1.15 to 1.08 (P
< .001). A total of 179 cases of intermittent claudication were identified during the 12-year follow-up. At baseline, ABI
in the worse leg of the claudicants was significantly lower than in healthy subjects (.99 vs 1.08; P < .01). In claudicants,
mean ABI in the worse leg fell by .04 over 5 years (P < .05) and in the better leg showed a highly significant drop of .09
(P < .001) to levels similar to those of the worse leg.
Conclusions: The mean ABI in the worse leg of study subjects showed little progression over 12 years. Individuals with
intermittent claudication experienced a greater decline in both legs compared with those without claudication. Deterio-
ration occurred more rapidly in the limb with a higher ABI at baseline, which possibly indicates a systemic tendency to
atherosclerosis. (J Vasc Surg 2003;38:1323-30.)
Measurement of the ratio of the ankle to brachial
systolic pressure (ABI) is widely used in clinical and epide-
miologic studies to determine the extent of atheroma in the
lower limb. Although the optimal cutoff level for an abnor-
mal ABI has not been validated so far, values below .9 have
been widely accepted as evidence of leg ischemia in most
epidemiologic studies. This is based on clinical practice, in
which an ABI of .9 has been reported to be over 90%
sensitive in detecting angiogram-positive peripheral ath-
erosclerosis.1
An ABI of .9 has been related to the prevalence of
angina, previous myocardial infarction and stroke, and at
least a twofold increased relative risk of fatal and nonfatal
cardiovascular events compared with those with an ABI
within the “normal” range.2-5 Significant associations be-
tween the ABI and other measures of subclinical cardiovas-
cular disease, such as carotid intima-media thickness, have
also been shown.7-9 However, in an earlier report from the
Edinburgh Artery Study, the probability of survival at 5
years was reduced, even among subjects with a baseline ABI
within the range 0.91 to 1.00 with the majority showing no
symptoms of peripheral arterial disease.6 This suggests that
symptom-free individuals who are at increased risk of future
clinical events may have an ABI in the “normal” range
when measured initially that could deteriorate over time.
Therefore, we wished to ascertain what typical changes
might occur in the ABI over time.
Measuring change in ABI over time in the general
population could also be useful in assessing progression of
atherosclerosis in the lower limb. To date, progression of
disease quantified with this index has only been investigated
in a small number of clinical studies of selected hospital
patients with intermittent claudication.10-16 However,
these patients would have had more severe disease than
those with peripheral arterial disease in the community, and
only individuals with symptoms would have undergone
diagnosis. The natural history of atherosclerotic disease
(measured quantitatively by using the ABI) in both claudi-
cants and nonclaudicants is not known in the general
population.
The Edinburgh Artery Study was established in 1987,
and it is the first large-scale cohort study in the United
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Kingdom to examine the natural history of peripheral arte-
rial disease in men and women from the general popula-
tion.17 This article presents results from over 12 years of
follow-up of the cohort. We report on changes in ABI
recorded at baseline and at 5-year and 12-year clinical
examinations in subjects overall, and in those with and
without intermittent claudication. Analyses of the effect of
cardiovascular risk factors on ABI are being undertaken,
and results will be presented in subsequent articles.
METHODS
Study population. The Edinburgh Artery Study be-
gan in 1987 as a cross-sectional survey of 1592 men and
women aged 55 to 74 years. The participants were ran-
domly selected by 5-year age bands from 11 general prac-
tices whose catchment areas were spread geographically
and socioeconomically throughout the city of Edinburgh.
The response rate was 65%, and assessment of 20% of the
nonresponders showed no substantial bias. Details of study
procedures and recruitment have been published previous-
ly.17 The study was approved by the Lothian Health Board
Ethics Committee, and informed consent was obtained
from each participant.
Clinical examinations. Subjects were invited to a uni-
versity or hospital clinic at baseline, and at 5 and 12 years
after the study commenced. At baseline, a self-administered
questionnaire was completed that contained validated
questions regarding personal characteristics, social class,
intermittent claudication and angina (World Health Orga-
nization [WHO] questionnaire),18 medical history, smok-
ing, diet and alcohol consumption, exercise, and current
medication. A modified questionnaire was repeated at the
5- and 12-year examinations.
Clinical measurements were conducted by trained re-
search staff during each examination. Systolic and diastolic
(phase V) blood pressures were recorded in the right arm
only, after 10 minutes rest in the supine position, by using
a Hawksley random zero sphygmomanometer. The femo-
ral, posterior tibial, and dorsalis pedis pulses were palpated
in both legs. Ankle systolic pressures were measured first in
the right leg and then in the left leg at the posterior tibial
artery, by using a Sonicaid Doppler ultrasound scanning
probe and a random zero sphygmomanometer with the
cuff placed proximal to the malleoli. The pulse was located
with the Doppler probe, and the cuff was inflated until the
pulse was no longer audible. The cuff was then deflated,
and the pressure was noted when the pulse re-appeared. If
the posterior tibial pulse was not detectable, the dorsalis
pedis pulse was used wherever possible.
At each clinic, 20 mL of venous blood was taken for
estimation of biochemical, rheologic, and hemostatic fac-
tors and for DNA extraction at 5 years. Standing height was
measured to the nearest 5 mm without shoes, and weight
was measured to the nearest 100 g on a digital Soehnle
scale. A 12-lead electrocardiogram was recorded and coded
independently by two readers using the Minnesota coding
system.19
Throughout the 12 years of follow-up, fatal and non-
fatal cardiovascular events were recorded by using criteria
adapted from the American Heart Association,20 and they
have been described in detail previously.21 To identify all
deaths occurring in the cohort, each participant’s record
was flagged at the UK NHS Central Registry so that death
certificates would be automatically forwarded to the inves-
tigators. If a postmortem was not performed, causes of
death were verified by consulting hospital or general prac-
titioner records. Intermittent claudication was recorded if
either of the following was true: (1) evidence of intermit-
tent claudication by World Health Organization (WHO)
criteria (grades 1, 2, or probable) at baseline or during
follow-up or (2) clinical diagnosis of intermittent claudica-
tion by general practitioner or in hospital. WHO claudica-
tion grade 1 is defined as pain only walking uphill or
hurrying, grade 2 as pain walking at an ordinary pace on the
level, and probable as calf pain without fulfillment of an
actual WHO criterion.
Data analysis. Information on the questionnaires and
recording forms were checked by the clinic staff and en-
tered onto a DBASE IV database. Error rates were mini-
mized by dual entry of all data, and reference was made to
original data if any disparity occurred. The ABI for each leg
was calculated by dividing the ankle systolic pressure by the
brachial systolic pressure. The lower of the two indices was
used as indicative of worse disease in the analysis. Differ-
ences in the population distribution of ABI at baseline, 5
years, and 12 years were illustrated by histogram. Note that
this was not limited to those subjects who had an ABI
measurement at all three examinations, but all population
values were available at each time point. In order to exam-
ine changes in ABI between the three clinical examinations
for better, worse, left and right legs, the analyses were
limited to those 695 subjects who had a valid ABI measure-
ment on both left and right legs at baseline, 5-year , and
12-year examinations. The significance of differences in
mean values of ABI between baseline and 5-year examina-
tion, 5- and 12-year examination, and between baseline
and 12-year examination were examined by using the
paired t test.
Each of the 695 subjects was assigned to a tertile group
on the basis of their baseline ABI value. For each tertile
group, graphs were plotted of the mean ABI of the better or
worse leg at baseline, 5-year, and 12-year examinations and
t tests performed to assess the significance of change in ABI
between the time points. The Student t test was used to
compare mean ABI between those who showed no evi-
dence of intermittent claudication at either baseline or
within the 12-year follow-up period and those who were
identified as having symptoms of intermittent claudication
at baseline or developing it during follow-up. This analysis
was performed on a subset of 986 subjects who had valid
ABI measurements at the baseline and 5-year examinations.
A P-value of .05 was taken to denote statistical signifi-
cance. The incidence of events indicating development or
progression of symptomatic peripheral arterial disease (new
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claudication, amputation and vascular surgery) during fol-
low-up by category of ABI is also shown.
RESULTS
At the baseline examination in 1987-1988, 1592 sub-
jects (809 men and 783 women) aged 55 to 74 years were
recruited to the Edinburgh Artery Study. After 5 years,
1156 (72.6%) attended a second examination, a further
131 (8.2%) subjects completed a questionnaire only, and
there were 203 deaths (12.8%), 89 of which were caused by
cardiovascular disease. Between 1999 and 2000, the third
clinical examination was conducted. A total of 837 subjects
attended the clinic, and a further 88 subjects completed a
questionnaire only. The total number of deaths recorded
by July 2000 was 485. Of these, 207 (42.7%) were cardio-
vascular, 105 died from a myocardial infarction, 51 subjects
had a fatal stroke, and 51 died from other vascular causes.
Six hundred and ninety-five subjects (348 men and 347
women) had valid ABI measurements on both legs at
baseline, 5-year, and 12-year examinations. Mean age
among the men at baseline was 65.21 (SE, .20) years and
64.49 (SE, .20) years among the women (P  .05).
Overall, one hundred and seventy-nine new cases of
intermittent claudication were identified during the 12-
year follow-up period. These included positive responses to
the WHO claudication questionnaire from the annual mail-
ing, the 5- or 12-year examinations, or notification from
general practitioners. Twenty-nine subjects (16.2%) were
classified as having grade 1 claudication, 43 (24.0%) had
grade 2, and 89 (49.7%) had probable claudication. A
further 18 (10.1%) had a general practitioner diagnosis of
intermittent claudication, but no WHO questionnaire evi-
dence. Of the 179 claudicants whose conditions were diag-
nosed during follow-up, 15 (8.4%) had undergone vascular
surgery or amputation during the follow-up period.
Figure 1 shows that there was a slight shift toward
lower mean ABI levels over time when the population
distribution of ABI at baseline, 5 years, and 12 years was
examined. Table I shows change in mean ABI level at
baseline, 5 years, and 12 years when the analyses was
Fig 1. Population distribution of ABI at baseline, 5 years and 12 years.
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restricted to only the 695 subjects who had a valid ABI
measurement at the three clinical examinations. The lower
ABI (indicating the worse leg at baseline) showed no
significant change over the 12 years of follow-up. Con-
versely, the leg with the higher ABI showed a significant
average drop over the first 5 years from 1.15 to 1.10 (SE for
both, .01), P  .001, and a further nonsignificant average
reduction of .02 (SE, .01) between 5 and 12 years, with
mean levels deteriorating toward those of the leg with the
lower ABI over time. On average, right leg ABI was higher
than left leg ABI at baseline, 1.13 versus 1.10 (SE for both,
.01), P  .001, with the right leg showing a greater
decrease (.05; SE, .01) over the 12 years than the left leg
(.03; SE, .01), although the difference was not statistically
significant. The relative reduction in ABI at the three time
points was then compared between the legs. Between base-
line and 5 years, the right leg showed a significantly greater
ABI reduction than the left leg (P  .001), and a similar
pattern was seen between baseline and 12 years (P  .05).
Figure 2 shows change in mean ABI in worse and better
Table I. Mean (SE) ABI in worse and better leg, right and left leg in all subjects at baseline, 5-year, and 12-year
examination
Mean (SE) ABI
N  695 Baseline 5 y 12 y
Change:
baseline to 12 y
Worse leg 1.08 (0.01) 1.08 (0.01) 1.07 (0.01) 0.01 (0.01)
Better leg 1.15 (0.01) 1.10* (0.01) 1.08 (0.01) 0.07* (0.01)
Right leg 1.13 (0.01) 1.09* (0.01) 1.08 (0.01) 0.05* (0.01)
Left leg 1.10 (0.01) 1.09† (0.01) 1.07‡ (0.01) 0.03* (0.01)
SE, Standard error; ABI, ankle brachial index; Worse leg, leg with lower ABI at baseline; Better leg, leg with higher ABI at baseline.
*P  .001;
†P  .01;
‡P  .05 for differences between stated or previous time periods.
Fig 2. Change in mean ABI in worse and better legs at baseline, 5 years and 12 years by tertiles. Tertile cut-points are
1.0319, 1.032-1.1279 and 1.128.
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leg over 12 years after classification of subjects according to
baseline ABI tertiles (1.0319, 1.032-1.1279, and
1.128). For the worse leg, subjects in both the highest
and lowest tertile showed a significant change in ABI, with
values converging toward those for the middle tertile group
in the first 5 years. Furthermore, subjects in the lowest
tertile showed a significant decrease in ABI between 5 and
12 years. There was little change in ABI levels for subjects in
the middle tertile during 12 years of follow-up. In general,
the pattern was similar for the better leg. Statistically signif-
icant drops in ABI were noted between baseline and 5 years
for subjects in the top and middle tertiles.
Analysis was then conducted on the worse and better
legs in men and women separately (Table II). Men had
significantly higher mean ABI levels at baseline than
women in both worse and better legs (both P  .001),
which was maintained throughout the 12 years (P .001).
In men, there were no significant changes in ABI during
follow-up in the worse leg, whereas the leg with the higher
ABI at baseline deteriorated relatively rapidly over the first
5 years, with a highly significant average drop of .07 (SE,
.01), P  .001, but then remained relatively unchanged
between the 5- and 12-year examinations. In women, a
different pattern emerged. A significant reduction in ABI
occurred between 5 and 12 years in the worse leg (P .01).
In the better leg, significant decreases in ABI were noted
between baseline and 5 years, and between 5 and 12 years,
which produced an overall drop in ABI from baseline to 12
years of .08 (SE, .01), P  .001. Comparing ABI distribu-
tions in men and women for the worse leg showed that men
had more low values, whereas the distribution in women
was more closely centered on the overall mean.
In Table III, the final analysis was based on a subset of
986 subjects who had valid ABI measures at baseline and 5
years. Changes in ABI for the leg with lower and higher
mean ABI at baseline were compared in subjects who had
no evidence of intermittent claudication (n 855), relative
to those 131 subjects who had intermittent claudication at
baseline or who developed claudication during follow-up.
Changes in ABI at the 12-year examination were not ana-
lyzed because of the death or nonattendance of some of the
participants. As expected, the overall ABI (minimum of
right or left leg) in the 131 claudicants was significantly
lower than the ABI of the healthy group (.99 vs 1.08; both
SE, .02; P  .01). For the leg with a lower baseline ABI,
mean ABI level of the claudicants fell on average by .04 over
5 years to .95 (SE, .02), P  .05, whereas there was no
significant change in the leg with a lower baseline ABI of
Table II. Mean (SE) ABI in worse and better leg of men and women at baseline, 5-year, and 12-year examination
Mean (SE) ABI
Baseline 5 y 12 y
Change:
baseline to 12 y
Men (n  348)
Worse leg 1.11 (0.01) 1.10 (0.01) 1.12 (0.01) 0.01 (0.01)
Better leg 1.19 (0.01) 1.12* (0.01) 1.13 (0.01) 0.06* (0.01)
Women (n  347)
Worse leg 1.04 (0.01) 1.05 (0.01) 1.02† (0.01) 0.02† (0.01)
Better leg 1.12 (0.01) 1.07* (0.01) 1.04* (0.01) 0.08* (0.01)
SE, Standard error; ABI, ankle brachial index; Worse leg, leg with lower ABI at baseline; Better leg, leg with higher ABI at baseline.
*P  .001;
†P  .01 for differences between previous or stated time periods.
Table III. Mean (SE) ABI at baseline and 5 years in subjects with intermittent claudication during 12-year follow-up




baseline to 5 y
Overall
Intermittent claudication (n  131) 0.99 (0.02) 0.91 (0.02) 0.08* (0.02)
No intermittent claudication (n  855) 1.08 (0.01) 1.04 (0.01) 0.03* (0.01)
Leg With Lower Baseline ABI
Intermittent claudication 0.99 (0.02) 0.95 (0.02) 0.04† (0.02)
No intermittent claudication 1.08 (0.01) 1.08 (0.01) 0.00 (0.01)
Leg With Higher Baseline ABI
Intermittent claudication 1.08 (0.01) 0.99 (0.02) 0.09* (0.02)
No intermittent claudication 1.16 (0.01) 1.09 (0.01) 0.07* (0.01)
SE, Standard error; ABI, ankle brachial index.
*P  .001;
†P  .05.
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those who remained free of symptomatic leg ischemia.
Both groups showed highly significant drops in ABI in the
leg with higher baseline ABI at 5 years (P  .001) with
levels falling toward those of the lower ABI leg.
The incidence of new vascular events (claudication,
vascular surgery, amputation) occurring during the 12
years of follow-up was related inversely to ABI at baseline
within the whole population (Table IV). The incidence
ranged from 22% in those with an ABI0.8 to 5% to those
with an ABI 1.2.
DISCUSSION
The present study is the first to evaluate changes in the
ankle brachial index at three time points, in both claudi-
cants and nonclaudicants over 12 years of follow-up in a
population-based study. The ABI provides an indirect mea-
sure of the hemodynamic effects of arterial narrowing
caused by peripheral atherosclerosis and is regarded as a
simple, reproducible diagnostic test for both subclinical
and clinical disease.22 We found that in the whole study
sample there was little change in mean ABI over 12 years in
the leg with the lower ABI at baseline. In contrast, the leg
with higher mean baseline ABI showed a significant drop
from 1.15 to 1.09 during follow-up. In claudicants, lower
mean baseline ABI fell by .04 over 5 years, whereas the leg
with the higher baseline ABI had a highly significant drop
of .09, and showed a greater rate of decline in both legs
compared with subjects with no claudication.
Baseline distribution of ABI. The mean ABI of the
worse leg (or lower baseline ABI) in the study sample of
men and women aged 55 to 74 years at baseline was 1.08
(SE, .01). This was estimated from the 695 subjects (43.7%
of those originally recruited) who had attended all three
examinations during the 12-year follow-up period. Hence,
subjects who had died during follow-up, or did not attend
subsequent clinics, were excluded from the first ABI anal-
ysis. In contrast, the baseline mean ABI of the worse leg
obtained from all 1592 subjects in the Edinburgh Artery
Study was lower at 1.03 (SE, .005),17 which demonstrates
that survivors and subsequent clinic attendees may have had
less generalized atherosclerosis. On average, at baseline, the
ABI in the worse leg was lower than in the better leg by .07
(SE, .01). It should be noted that, in comparing population
studies, differences in overall ABI result not only from
severity of underlying atherosclerosis, but also from varia-
tions in age and sex distribution, risk factor burden, ethnic-
ity, and from the method of calculating the ABI. In the
present study, mean ABI was comparable with that found
in European population surveys, which have similar age
ranges.23,24 Conversely, the relatively younger population
in the Atherosclerosis Risk in Communities Study (45-64
years) had a higher mean ABI of 1.17, but ankle systolic
pressure was calculated on only one leg, and this may have
contributed to the underestimation of disease severity.25 In
two more elderly American populations of men 70 years
of age,26 and men and women 65 years of age,7 average
ABI within both populations was of a similar magnitude to
our own findings.
In this study sample, the baseline ABI was higher in the
right leg compared with the left leg by an average of .03
(SE, .01), whereas a slightly smaller average difference of
.02 (SE, .01) was noted between right and left legs for the
entire Edinburgh Artery Study population, with greater
variation occurring when mean ABI levels were lower.17
Asymmetry in ABI of the lower limbs has also been shown
in both studies of healthy individuals,27 and patients at-
tending a vascular laboratory with a diagnosis of intermit-
tent claudication or an ABI .95 in either or both legs.28
This could reflect a unilateral predisposition to atheroscle-
rosis because it has been demonstrated that there is minimal
systematic variation in measurement of pressure between
each leg.22 However, the order in which pressures are taken
may influence the levels of recorded systolic pressures.
Central aortic pressure tends to fall as length of rest in the
supine position increases. Hence, a higher pressure would
be recorded in the first leg in which pressure is measured
(usually the right leg as in the present study) and a lower
pressure would then tend to occur in the left leg as the
central aortic pressure continued to fall.
On average, men had values of ABI that were .07
higher (SE, .01) than those of women in both the worse
and better legs. Sex differences in the distribution of the
ABI have been observed in most other population studies,
with men consistently recording a higher ABI.23-25,27 In
contrast, an Israeli population study found no difference in
ABI between men and women, but this was conducted on
a younger population overall.29 Height may partly explain
the differences between the sexes, and it has been estimated
that for each 10-cm increase in height, ankle systolic pres-
sure is raised by 1 mm Hg.27 However, in the present study,
the distribution of the ABI appeared different in men
compared with women, with men having relatively more
low values, and a greater variance (spread) of ABI com-
pared with women (data not shown).
Change in ABI over time. In the study sample, the
overall mean ABI in the worse leg showed little change over
12 years of follow-up. This was also noted when the study
population was subdivided by sex. Compared with the
Table IV. Incidence of vascular events (new claudication,












 1.20 11 5.2
ABI, Ankle brachial index.
*One subject who had an event did not have the ABI measured at baseline.
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results from a small number of hospital studies of claudi-
cants, the ABI levels of symptom-free subjects in the
present study decreased less over time, whereas ABI levels
in claudicants appear to deteriorate at a variable rate that
may depend partly on severity of disease at presentation.
For example, one clinical study of claudicants with a mean
ABI at baseline of .58 reported a decline of .014 per year
(approximately equivalent to .07 over 5 years)15, compared
with .04 over 5 years in the leg with a lower ABI at baseline
in the present study. In contrast, an average decline of .02
over 4.6 years follow-up was shown in patients with a
slightly lower ABI at baseline of .90.14 However, those who
required intervention (and were likely to have had more
severe disease) were excluded from the analyses, and hence,
this particular study may have underestimated the true rate
of disease progression. Furthermore, because both of these
clinical studies had an extremely high proportion of sub-
jects with diabetes, the results cannot be extrapolated to
claudicants in the general population.
Of interest in our study was the finding that progres-
sion of atherosclerosis in the leg that had a higher ABI at
baseline occurred more rapidly than in the leg that had
evidence of more severe disease, and this was consistent
within each subgroup we analyzed. When angiography or
duplex scanning has been used to document disease pro-
gression in patients with symptoms, it has been found that
an isolated stenosis is usually found in the “asymptomatic”
leg, often symmetrically opposite the distal end of an oc-
clusion in the symptomatic leg.30 Walsh et al31 reported
that if a femoral occlusion was present, lesions or stenoses
occurring in the opposite leg deteriorated more rapidly.
This may be caused by the degree of narrowing, which
precipitates total occlusion, or by the development of col-
lateral vessels in the more affected leg that minimizes
ischemia and would result in little change to the ABI.
Limitations of methods. In order to assess changes in
ABI over the 12-year period, subjects who had died or did
not attend all three examinations had to be excluded from
the analyses. Because during follow-up there were a sub-
stantial number of deaths from cardiovascular disease of
subjects who were more likely to have a lower ABI at
baseline or whose ABI deteriorated at a faster rate than that
of other subjects, it is probable that selective survival bias
may have underestimated the magnitude of the progression
of atherosclerosis. This may have been reflected in the lack
of relative change in the ABI. In addition, we are aware that
an ABI may be normal at rest but can become abnormal
after exercise or with a stress test. A reactive hyperemia test
was administered at baseline but was found to be unaccept-
able to a substantial number of subjects and was not re-
peated. Although it is conceivable that individuals with
some degree of peripheral atherosclerosis may have been
missed, it is change in values of ABI between groups rather
than peripheral arterial disease that is being assessed in this
study, and therefore, the validity of the test in detecting
disease is not such an important issue. Also, this is a
population-based study rather than a clinical study of se-
lected hospital patients at the severe end of the disease
spectrum. The mean ABI reported for each leg is the mean
for the whole study sample, which will include values for
subjects who will have deteriorated clinically and others
who have not. Therefore, although the changes in ABI that
we report may be of little relevance to a clinician, they are
valid in the context of the distribution of ABI within
defined populations.
Another factor that may have reduced the overall mean
change in ABI over time is “regression to the mean,” an
effect that occurs when repeated measurements are made of
a variable. This causes extreme values to become closer to
the mean on subsequent remeasurement and so produces
an underestimation of mean change. In addition, we did
not exclude individuals with an ABI 1.50, a ratio that is
associated with arterial calcification, and with increases
arterial wall stiffening, as found, for example, in diabetics.
This could also potentially introduce some systematic bias,
although there were only three subjects in the present study
with this extreme value.
Interobserver variability has also been shown to affect
the validity of ABI measurement in clinical studies, espe-
cially when measurement of ABI has been performed by
inexperienced technicians.28,32 This may have been a factor
in the present study, given that only a single measurement
was taken by different observers at each of the three clinical
examinations. Finally, the ability of the ABI to accurately
detect peripheral arterial disease progression has recently
been questioned. In a study of 114 patients who had
undergone iliac or femoral bypass surgery, in comparison
with duplex scanning or angiography, the ABI was found to
be relatively insensitive (41%) at detecting progression of
peripheral atherosclerosis.13 However, the overall trends in
ABI in the Edinburgh Artery Study were as expected, and
any of the limitations discussed earlier would not affect
subgroups differentially. Hence, we are confident that the
differences we have observed are meaningful.
In conclusion, among subjects selected from the gen-
eral population, the lower ABI obtained from the two legs
showed little progression over 12 years of follow-up. Dete-
rioration occurred more rapidly in the limb with the higher
ABI, possibly indicating a systemic tendency to atheroscle-
rosis. Individuals who had intermittent claudication tended
to experience a greater decline in the ABI of both legs
compared with symptom-free subjects. Further longitudi-
nal studies are required to investigate the relevance of
changes of ABI over time in the general population and to
compare this method of assessment of atherosclerosis with
imaging techniques to determine valid estimates of disease
progression.
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